Biolyph Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Biolyph

Access the complete profile.

Biolyph Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	621511 Medical Laboratories
Additional NAICS Codes	325413 In-Vitro Diagnostic Substance Manufacturing
Address	4275 Norex Drive Chaska, MN 55318

Note: Revenues for privately held companies are statistical evaluations.


Biolyph's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Biolyph's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Biolyph is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Biolyph Annual Revenue and Growth Rate

Biolyph	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Biolyph's revenues are gauged from an analysis of company filings.

Biolyph's Income Statement (based on Industry Averages)

Biolyph P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Biolyph is developing and marketing. Biolyph doesn't have any recent trademark applications, indicating Biolyph is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
HEMATUBE An evacuated blood collection tube containing one or more lyophilized inhibitors	08/26/2013

See all trademarks and details in the Full Report.

Market Share of Biolyph's Largest Competitors

A competitive analysis shows these companies are in the same general field as Biolyph, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Biolyph. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BIOLYPH	Chaska, MN	100
DIAMEDICA USA	Minnetonka, MN	14
PRIOR LAKE DENTAL PLLC	Prior Lake, MN	11
GATHERWELL PLLC	Ham Lake, MN	10
COLLAGEN SOLUTIONS US	Eden Prairie, MN	5
VIA BIOMEDICAL	Mound, MN	1

Future Competition: Biolyph's Fastest Growing Competitors

These companies are in the same general field as Biolyph and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)